9NP

(2S)-N,2-dicyclohexyl-2-{2-[4-(1H-tetrazol-5-yl)phenyl]-1H-benzimidazol-1-yl}acetamide

Created:	2017-05-19
Last modified:	2017-07-05

Find Related PDB Entry
1 entries where 9NP is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	69
Chiral Atom Count	1
Bond Count	74
Aromatic Bond Count	21

2D diagram of 9NP

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S)-N,2-dicyclohexyl-2-{2-[4-(1H-tetrazol-5-yl)phenyl]-1H-benzimidazol-1-yl}acetamide
Systematic Name (OpenEye OEToolkits)	(2~{S})-~{N},2-dicyclohexyl-2-[2-[4-(1~{H}-1,2,3,4-tetrazol-5-yl)phenyl]benzimidazol-1-yl]ethanamide
Formula	C₂₈ H₃₃ N₇ O
Molecular Weight	483.608
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	n4c1c(cccc1)n(C(C(=O)NC2CCCCC2)C3CCCCC3)c4c6ccc(c5nnnn5)cc6
SMILES	CACTVS	3.385	O=C(NC1CCCCC1)[CH](C2CCCCC2)n3c4ccccc4nc3c5ccc(cc5)c6[nH]nnn6
SMILES	OpenEye OEToolkits	2.0.6	c1ccc2c(c1)nc(n2C(C3CCCCC3)C(=O)NC4CCCCC4)c5ccc(cc5)c6[nH]nnn6
Canonical SMILES	CACTVS	3.385	O=C(NC1CCCCC1)[C@H](C2CCCCC2)n3c4ccccc4nc3c5ccc(cc5)c6[nH]nnn6
Canonical SMILES	OpenEye OEToolkits	2.0.6	c1ccc2c(c1)nc(n2[C@@H](C3CCCCC3)C(=O)NC4CCCCC4)c5ccc(cc5)c6[nH]nnn6
InChI	InChI	1.03	InChI=1S/C28H33N7O/c36-28(29-22-11-5-2-6-12-22)25(19-9-3-1-4-10-19)35-24-14-8-7-13-23(24)30-27(35)21-17-15-20(16-18-21)26-31-33-34-32-26/h7-8,13-19,22,25H,1-6,9-12H2,(H,29,36)(H,31,32,33,34)/t25-/m0/s1
InChIKey	InChI	1.03	WMTZCRYRUZAGRY-VWLOTQADSA-N

Related Resource References

Resource Name	Reference
PubChem	25133089

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.